Form 4: CVS Health Director Larry Robbins Reports Acquisition of Deferred Stock Units

Director Larry Robbins reports acquisition of deferred stock units in CVS Health Corp.

Summary

• On May 15, 2025, Larry Robbins, a director of CVS Health Corp, acquired deferred stock units.
• These units are related to the deferral of a semi-annual retainer under the company's non-employee director compensation policy.
• The transaction involved 2,769.9686 deferred stock units, each convertible into one share of common stock upon Robbins' retirement from the Board of Directors.
• The price of the deferred stock units was $60.47.
• Following the transaction, Robbins directly owns 5,766.7068 deferred stock units.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects standard director compensation practices and aligns director interests with the company's long-term performance.

Future Outlook

The deferred stock units will be converted into common stock upon the reporting person's retirement from the Issuer's Board of Directors.

Industry Context

This filing is a routine disclosure related to director compensation and equity ownership, common in publicly traded companies. It provides transparency into the alignment of director interests with shareholder value.

Stakeholder Impact

• The transaction provides transparency to shareholders regarding director compensation and equity ownership.
• It aligns the director's interests with the long-term performance of the company.

Key Dates

Keywords

CVS Health, Larry Robbins, Deferred Stock Units, Director Compensation, Form 4, SEC Filing